<code id='331B7473F6'></code><style id='331B7473F6'></style>
    • <acronym id='331B7473F6'></acronym>
      <center id='331B7473F6'><center id='331B7473F6'><tfoot id='331B7473F6'></tfoot></center><abbr id='331B7473F6'><dir id='331B7473F6'><tfoot id='331B7473F6'></tfoot><noframes id='331B7473F6'>

    • <optgroup id='331B7473F6'><strike id='331B7473F6'><sup id='331B7473F6'></sup></strike><code id='331B7473F6'></code></optgroup>
        1. <b id='331B7473F6'><label id='331B7473F6'><select id='331B7473F6'><dt id='331B7473F6'><span id='331B7473F6'></span></dt></select></label></b><u id='331B7473F6'></u>
          <i id='331B7473F6'><strike id='331B7473F6'><tt id='331B7473F6'><pre id='331B7473F6'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:78319
          Robert F. Kennedy Jr.
          Robert F. Kennedy Jr. arrives in the lobby of Trump Tower in New York for a meeting with President-elect Donald Trump. Evan Vucci/AP

          WASHINGTON — Outspoken vaccine critic Robert Kennedy Jr. said Tuesday that he had accepted a position in Donald Trump’s administration as chair of a panel on vaccine safety and scientific integrity, in what would be the clearest sign yet of the president-elect’s suspicions about vaccines.

          Kennedy’s remarks followed his meeting with the president-elect at Trump Tower and immediately sparked outrage from scientists, pediatricians, and public health experts, who fear the incoming administration could give legitimacy to skeptics of childhood immunizations despite a huge body of scientific research demonstrating that vaccines are safe. Many of those skeptics believe vaccines are a cause of autism.

          advertisement

          Hours later, Trump spokeswoman Hope Hicks said in a statement that the president-elect was “exploring the possibility of forming a commission on Autism,” but said “no decisions have been made at this time.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          How to make over
          How to make over

          AdobeTheFoodandDrugAdministrationrecentlyapprovedOpill,thefirstover-the-counteraccessbirthcontrolpil

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          National associations that represent hospice owe an apology

          JohnMoore/GettyImages“Howhastheclinicalworkyoudoaffectedyoupersonally?”We’dcometotheQ&Apartofthe